Press release
May 12th Deadline in Lawsuit for Investors in shares of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) coming up
A Deadline is coming up on May 12, 2020 in the lawsuit for certain investors in Inovio Pharmaceuticals, Inc. (NASDAQ: INO).
Investors who purchased shares of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) have certain options and there are strict and short deadlines running. Deadline: May 12, 2020. NASDAQ: INO stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
According to the complaint filed in the U.S. District Court for the Eastern District of Pennsylvania the plaintiff alleges on behalf of purchasers of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) common shares between February 14, 2020 and March 9, 2020, that the defendants violated Federal Securities Laws. More specifically, the plaintiff claims that between February 14, 2020 and March 9, 2020, Inovio made misleading statements about the company's development of a purported vaccine for the novel coronavirus, artificially inflating the company's share price and resulting in significant investor losses.
Those who purchased shares of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) have certain options and should contact the Shareholders Foundation.
Media Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com
About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release May 12th Deadline in Lawsuit for Investors in shares of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) coming up here
News-ID: 2028252 • Views: …
More Releases from Shareholders Foundation
Lawsuit Alert: Investors who lost money with James Hardie Industries plc (NYSE: …
An investor, who purchased shares of James Hardie Industries plc (NYSE: JHX), filed a lawsuit over alleged violations of Federal Securities Laws by James Hardie Industries plc in connection with certain allegedly false and misleading statements.
Investors who purchased shares of James Hardie Industries plc (NYSE: JHX) have certain options and for certain investors are short and strict deadlines running. Deadline: December 23, 2025. NYSE: JHX investors should contact the Shareholders…
Investigation announced for Long-Term Investors in SelectQuote, Inc. (NYSE: SLQT …
An investigation on behalf of current long-term investors in shares of SelectQuote, Inc. (NYSE: SLQT) concerning potential breaches of fiduciary duties by certain directors and officers of SelectQuote, Inc. was announced.
Investors who are current long term investors in SelectQuote, Inc. (NYSE: SLQT) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term…
Lawsuit filed for Investors who lost money with shares of MoonLake Immunotherape …
An investor, who purchased shares of MoonLake Immunotherapeutics (NASDAQ: MLTX), filed a lawsuit over alleged violations of Federal Securities Laws by MoonLake Immunotherapeutics in connection with certain allegedly false and misleading statements.
Investors who purchased a significant amount of shares of MoonLake Immunotherapeutics (NASDAQ: MLTX) between March 10, 2024 and September 29, 2025, have certain options and for certain investors are short and strict deadlines running. Deadline: December 15, 2025. NASDAQ:…
Dow Inc. (NYSE: DOW) Investor Alert: Deadline in Lawsuit on October 28, 2025
A deadline is coming up on October 28, 2025 in the lawsuit filed for certain investors of Dow Inc. (NYSE: DOW) over alleged securities laws violations by Dow Inc.
Investors who purchased shares of Dow Inc. (NYSE: DOW) have certain options and there are strict and short deadlines running. Deadline: October 28, 2025. Dow Inc. (NYSE: DOW) stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
More Releases for Inovio
DNA Nanotechnology Market Top Players - NuProbe, GATTAQUANT GMBH, Genisphere LLC …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global DNA Nanotechnology Market - (By Type (Structural DNA Nanotechnology (Extended Lattices, Discrete Structures, Template Assembly), Dynamic DNA Nanotechnology (Nanomechanical Devices, Strand Displacement Cascades)), By Application (Targeted Drug Delivery, Smart Pills, Nanolithography, Others), By End User (Biotechnology & Pharmaceutical Companies, Academic & Research Institutions, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2031."
According to the…
U.S. Vaccines Market All Sets For Continued Outperformance | GSK, Inovio Pharmac …
Market Research Forecast added research publication document on Worldwide U.S. Vaccines Market breaking major business segments and highlighting wider level geographies to get deep dive analysis on market data. The study is a perfect balance bridging both qualitative and quantitative information of Worldwide U.S. Vaccines Market. The study provides valuable market size data for historical (Volume** & Value) from 2019 to 2022 which is estimated and forecasted till 2030*. Some…
Global Therapeutic Vaccines Market 2020 Business Strategies – Valeant Pharmace …
The market report titled “Therapeutic Vaccines Market by Products (Addiction Vaccines, Autoimmune Disease Vaccines, Infectious Disease Vaccines and Neurological Disease Vaccines) and by Technology (Autologous Vaccine and Allogeneic Vaccine): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022” and published by Zion Market Research will put forth a systematizedevaluation of the vital facets of the global Therapeutic Vaccines Market market. The report willfunction as a medium for the better…
Global Therapeutic Vaccines Market 2020 Business Strategies – Valeant Pharmace …
The Zion Market Research added a new report “Therapeutic Vaccines Market by Products (Addiction Vaccines, Autoimmune Disease Vaccines, Infectious Disease Vaccines and Neurological Disease Vaccines) and by Technology (Autologous Vaccine and Allogeneic Vaccine): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 - 2022” in its database, which provides an expert and in-depth analysis of key business trends and future market development prospects, key drivers and restraints, profiles of major market…
Investigation announced for Investors in shares of Inovio Pharmaceuticals, Inc. …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Inovio Pharmaceuticals, Inc.
Investors who are current long term investors in Inovio Pharmaceuticals, Inc. (NASDAQ: INO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.
The investigation by a law firm for current long term investors in NASDAQ: INO stocks follows a lawsuit filed against Inovio Pharmaceuticals,…
Lawsuit filed for Investors in shares of Inovio Pharmaceuticals, Inc. (NASDAQ: I …
The Shareholders Foundation announced that an investor, who purchased shares of Inovio Pharmaceuticals, Inc. (NASDAQ: INO), filed a lawsuit over alleged violations of Federal Securities Laws by Inovio Pharmaceuticals, Inc..
Investors in shares of Inovio Pharmaceuticals, Inc. (NASDAQ: INO) have certain options and for certain investors are short and strict deadlines running. Deadline: May 12, 2020. NASDAQ: INO investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -…
